Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: A Comparison of Two Initial Dosing Formulas [NA]
A completed clinical trial evaluating two initial dosing formulas for Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study [NA]
This document reports an update on a completed clinical trial studying basal insulin dosing requirements in adults with Type 2 Diabetes Mell…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)
A completed clinical trial (MK-0431-402) evaluated the incidence of low blood sugar events in people with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin [Phase 3]
A Phase 3 trial evaluated adding dapagliflozin to insulin therapy in adults with type 2 diabetes inadequately controlled on insulin, assessi…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension [Phase 3]
Phase 3 trial update from AstraZeneca reports efficacy and safety results in patients with type 2 diabetes mellitus, cardiovascular disease …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease [Phase 3]
Phase 3 trial results evaluating efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease have been posted; …
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial update from AstraZeneca reports results evaluating efficacy and safety in Japanese subjects with Type 2 diabetes me…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of dapagliflozin in combination with metformin in adults with Type 2 diabetes; results were…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial evaluated the safety and efficacy of KRP-104 added to metformin in adults with …
-
FDA approval · 2013-08-21FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro (and its diluent) from Eli Lilly, signaling an update to the product's regulatory…
-
FDA approval · 2013-08-21FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes
This clinical trial update reports the completion of a study evaluating endothelial function in young Hispanic adults at risk for Type 2 dia…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes
A completed Joslin Diabetes Center clinical trial evaluating endothelial function in Hispanic children and adolescents at risk for type 2 di…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients [NA]
A ClinicalTrials.gov trial evaluated the impact of different interventions on glycemic control and beta-cell function in adults newly diagno…
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients [Phase 4]
A Phase 4 study assessed how body weight affects the efficacy of metformin (Glucophage) in Chinese patients diagnosed with type 2 diabetes m…
-
FDA approval · 2013-08-19FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUVIA (sitagliptin) from Merck Sharp & Dohme LLC. The supplemental action updates the drug…
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil [Phase 1]
Phase 1 bioequivalence study in Brazil comparing fixed-dose combination Saxagliptin/Metformin to coadministered tablets in type 2 diabetes; …
-
FDA approval · 2013-08-16FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approves TEVA Pharmaceuticals USA Inc's supplemental application for GLYBURIDE. The action updates the approved glyburide product throug…
-
FDA approval · 2013-08-15FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Actoplus Met, a fixed-dose combination of pioglitazone and metformin hydrochloride, submitte…
-
FDA approval · 2013-08-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA granted supplemental approval for insulin lispro from Eli Lilly (BLA020563), updating the product's regulatory status.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) to incorporate the KwikPen delivery device for the pre…
-
FDA approval · 2013-08-15FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for alogliptin by Padagis Israel Pharmaceuticals Ltd.